Interim analyses
The report is available on request. The resolution from Prof. Lengeler, chair of the Scientific Advisory Board (SAB) is attached below.
From:
lengeler <Christian.Lengeler@xxxxx.xx> To: Date:
6/10/2008 3:01 pm Subject:
Interim analysis and report
Dear Kalanet SAB and Dear Kalanet team.
In the absence of any further correspondence and inputs in the matter of the interim analysis and report (submitted by the Kalanet team in April of this year) I would like to confirm that the Kalanet Scientific Advisory Board accepts the reports and recommends continuation of the trial along the lines agreed previously. 
Direct Agglutination Test (DAT) protocol
The Direct Agglutination Test (DAT) was performed using freeze dried antigen suspension of trypsin-treated, fixed and stained promastigote of L. donovani from ITM-Antwerp. The filter papers Whatman #3 with the blood samples, kept at -20 o C until the test was conducted, were warmed up to room temperature. To obtain a 1:400 dilution, a standard 5 mm filter paper disc fully covered with blood was punched out from the filter paper and eluted in 1000 µL DAT buffer (PBS-PH 7.2 supplemented with protein). After 12h incubation at 4°C, 100 µl were transferred to the first well of a V-shaped microtiter plate. To obtain serial dilutions from 1:400 to 1:25600, 50 µl of the dilution were mixed with 50 µl of DAT-diluent including 2-Mercapto-Ethanol (preparation: 0.24 ml 2-ME per vial of 30ml DAT-diluent) in the subsequent wells using a multi-channel pipette. Serum was diluted from 1:400 to 1:25600. Then, (1) 50 µL of DAT antigen were added in each well; (2) the plate was sealed, (3) shaken gently, and (4) incubated overnight at ambient temperature. One positive and 1 negative controls were run every 5th plate. Reading: the tests were read against a white background by two independent readers. A third reader was called as a referee if no consensus was found in the reading. a) Adjusted for age group, gender, times sprayed and socio-economic status.
Visceral Leishmaniasis case definitions.

Number of VL cases and people at risk per pair and cluster
Subgroup analyses
Material and Methods
Subgroup analyses were carried out for the effect of longlasting insecticidal bed nets (LNs) on L. donovani infection by country, age (<14, 14 to 38 and >38 years old) and socioeconomic status (SES) groups. To test for effect modification, the effect of intervention was compared in the youngest age group (<14) with the older age group (≥ 14) and the lowest SES group compared to the rest. The effect of LNs was analyzed using higher DAT cut offs.
Results
The analysis of the effect of LNs by increasing age showed a trend, with the RR ranging from 0.69 in the youngest age group to 1.15 in the oldest, but none of the RRs were statistically significant ( ). An analysis of LN effect by SES group showed no major differences (data not shown).
When higher cut-offs were used in DAT for defining seroconversion, the protective effect of LNs seemed to progressively increase up to RR=0.80 when a titre cut-off 1:12800 was used, the effect was however nonstatistically significant and this trend disappeared in the adjusted model (table 7.1). 
Effect of LNs on Visceral Leishmaniasis (VL) taking 6 months incubation period
The effect of bed net (LN and untreated) use.
Methods
The effect of bed net use on the risk of seroconversion was examined by comparing the number of seroconverters in three groups: LN group (intervention clusters) and people with and without an untreated net in control clusters. The statistical methods described in the manuscript for the primary analyses were applied. Table 11 .1 presents the number of individuals and proportion of seroconversions per group. As expected the group using treated nets is the largest (50%, 6372/12690) as this corresponds to the intervention group. We do, however, have 12% (1557/12690) of the subjects, who report not using nets. This proportion differs between India and Nepal as 18% (1298/7367) of the Indian study population do not use nets compared to 5% (259/5323) of the study population from Nepal. The overall proportion of seroconverters was highest in the group of individuals not using bed nets (although this was perhaps not the case in India). Table 11 .2 shows the effect of bed net use on the risk of seroconversion. Overall the risk of seroconversion decreased by 29% for treated nets compared to no net use. This decrease is, however, not statistically significant as the confidence interval includes 1 (p=0.2834). Most of this effect is due to the effect in Nepal, where the treated nets reduce the risk by 75% compared to no nets (this effect is borderline statistically significant, p=0.0530). The overall risk ratio is borderline statistically significant after adjusting for age group, gender, times sprayed and socio-economic status (p=0.0579). The adjusted risk ratio is 0.45 (95% CI 0.19 to 1.03) this change is mainly due to the change when adjusting in India where using treated nets now becomes beneficial. In the control clusters, the overall risk of seroconversion decreased by 48% for people using nets compared to people without nets, the effect is borderline statistically significant (p=0.049) in the unadjusted model but not in the adjusted model (p=0.087).
Results
In general the two groups using nets have very similar risks of seroconverting and the main difference lies in the group not using nets (Table 11. 2). There are no statistically significant differences between the two groups using nets.
Primary analysis not accounting for pairing
Some studies suggest that in community trials with a small number of pairs the pairing can be ignored in the analyses. 1 Table 12 .1 shows the results from the primary analysis on the cluster level, but ignoring the pairing. The results and confidence intervals obtained are similar to those obtained in the analysis taking into account the pairing (see manuscript for further details). 
Coefficient of intraclass correlation (ICC).
Assumed ICC:
The coefficients of intraclass correlation (ICC) were estimated from the coefficient of variation (k) using the formula for binary outcomes described in Hayes & Moulton (2009 -page 18; section 2.3.4) 1 . For the sample size calculation the coefficient of variation was assumed to be 0.25 corresponding to the intracluster correlation coefficient of 0.003 (ignoring pairing and setting the overall risk of seroconversion to 0.04).
Observed ICC: It is impossible to estimate the intracluster correlation coefficient of the coefficient of variation based on data from a matched trial because the between-cluster variability is confounded with variations in the intervention effect. However, ignoring the pairing, the observed ICC could be estimated as 0.03. 
Quality control Direct Agglutination Test
The Direct Agglutination Test (DAT) was done by survey batches in two laboratories: B.P Koirala Institute of Health Sciences (BPKIHS) in Dharan, Nepal for the samples taken in Nepal and Banaras Hindu University (BHU) in Varanasi, India, for the Indian samples. The laboratory of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium was used as a reference laboratory.
Before the trial: A standardisation workshop was organised at BPKIHS in Dharan before starting the trial. To confirm that the protocol was well standardised in both countries, 100 samples (non trial-related) were exchanged between laboratories and the DAT results compared.
During the trial: During the serosurveys three blood spots were collected from each consenting participant. The third spot, identified as "QC", was for quality control purposes exclusively (Figure 14.1) .
For each one of the three immunological surveys, 10 % of samples in each country were selected on the following basis: a random sample of 10% of all DAT-negative samples and a random sample of 10% of the DAT-positive samples. These samples were exchanged between country laboratories, re-tested and the results compared. Discordance was defined as a titer difference of 2 or more between the results from the two laboratories in a given sample. The discordant samples were sent to the reference laboratory in ITM-Antwerp for definitive classification.
Results were plotted in Bland Altman and scatter plots to check for systematic errors. The Kappa test was used to compare the results on the QC samples. Discordance rate was calculated by cluster, by day and by batch of antigen to examine clustering.
Conclusion:
Between laboratory reproducibility was good and comparable with previous studies. 1 No systematic errors were found. Errors were randomly spread in the total set of samples.
Figure Add-14.1: Design of the filter paper used to collect blood samples for Direct Agglutination Test (DAT). Three blood spots were taken in each immunological survey, the last spot (QC) was used for Quality Control.
Trial outcomes analysed using a random effects logistic regression model
Materials and Methods: Cluster-specific odds ratios (OR) for the trial outcomes (DAT seroconversion, VL, malaria and all causes of death) were obtained applying a logistic regression model using the individual level data and including a fixed effect of pair and a random effect of cluster to take the matching and the clustering into account respectively. In a second step the basic model was adjusted for a series of covariates: age and gender at individual level, IRS and social status at household level and country at cluster level. First each covariate was added one at a time to the basic model as a fixed effect to investigate their individual impact on the intervention effect. Finally, all the potential confounders were included simultaneously. Only the latter results are presented below. For the adjusted analyses, the age of the individuals at baseline was grouped into five approximately equally sized groups 0-4, 5-11, 12-23, 24-39 and 40+. The information on number of times each household was sprayed during the trial was grouped as 0, 1 and 2 or more. A score was calculated for each household to reflect the socio-economic position of the family. These scores were grouped into five equal groups (within country) where 0 represents the poorest group and 4 the least poor group.
Results: Table Add-15.1 summarises the effect of LN on DAT seroconversion, incident VL, malaria and all causes of death using a multilevel model. When the individual data were analysed using the mixed logistic regression model, the overall odds for L. donovani infection were reduced in the individuals living in intervention clusters by 9% compared to individuals in control clusters. The effect was, however not statistically significant (OR=0.91; 95% CI: 0.62-1.34). The results were not significantly modified in the adjusted model (OR=0.91; 95% CI 0.61-1.37). When the individual data were analysed per country LNs seem to have an opposite effect on DAT seroconversion in India (OR=1.13) and Nepal (OR=0.62) but the effect was in both cases non-statistically significant in the crude analysis. Similar results were obtained in the adjusted model: OR=1.17 and 0.51 in India and Nepal respectively. The mixed logistic regression model showed that LNs reduced the odds of VL by 11% (OR=0.89; 95% CI 0.57-1.40), but the effect was, again, not statistically significant and did not change in the adjusted model. Results per country were similar to the overall effect. The overall effect of LNs on malaria showed a statistically significant reduction of cases in intervention clusters (OR=0.61; 95% CI 0.42-0.89) which was slightly increased post-adjustment (OR=0.56; 95% CI 0.39-0.78). The results observed on malaria cases were mainly based on the effect of LNs in India due to the bias on the number of cases (220/225 malaria cases reported in India). Similarly the total number of deaths was reduced in intervention clusters (OR=0.72; 95% CI 0.56-0.93) and this effect was greater in India than in Nepal.
Discussion: Table Add-15.2 presents the trial results obtained from the cluster level model (Relative Risk = RR) used in the manuscript and the multilevel model presented above. The trial results obtained using a multilevel model (mixed logistic regression) were analogous to those obtained using a cluster level model (presented in the manuscript). The effect of LN on L. donovani infection (the main outcome) was almost identical (RR=0.90 and OR=0.91) and non-statistically significant in both models. The effect on VL cases was larger in the mixed model (OR=0.89) compared to the cluster level model (RR=0.99) but was non-statistically significant in both cases. LN reduced the number of malaria cases, this effect was similar in both models (RR=0.63 and OR=0.61) but was only statistically significant in the crude multilevel model. The effect of LN on malaria was increased (RR=0.46 and OR=0.56) and was statistically significant in both adjusted models. The main difference was that the mixed model was able to detect a statistically significant effect of LN on all causes of death, the magnitude of the effect was however similar in both cases: RR=0.75 and OR=0.72. The conclusions of the trial were not modified when an alternative analytical method was used. 16. Effect of LN excluding clusters (C11 and C55) with high seroconversion rates (outliers).
Material and Methods:
Clusters C11and C55 had a very high seroconversion rates compared to the rest of clusters. Those clusters could be considered outliers. To asses their impact on the trial outcomes, the effect of LN on L. donovani infection was re-analysed excluding those clusters. The analytical method used was the same described in the manuscript. In this new analysis pairing was not taken into account.
Results:
The results of the effect of LN on L. donovani infection obtained excluding the outliers (clusters C11 and C55) detailed in Table Add -16.1 are similar to those reported in the manuscript: RR=0.88 and RR=0.89 respectively. Both effects were non-statistically significant. 
